IP Library › Assignment 035319/0001
Patent Assignment
Reel/Frame 035319/0001

Release of Security Interest

Recorded: 2015-04-02 Pages: 15
Assignor
Assignee
SIGA TECHNOLOGIES, INC.
660 MADISON AVENUE, SUITE 1700, NEW YORK, NEW YORK, 10065
Covered Properties (22)
Sulfonyl Semicarbazides, Carbonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 7,994,221 →
Application: 11/653,972 →
Publication: US 2010/0256096
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 7,872,037 →
Application: 11/712,918 →
Publication: US 2007/0254934
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Patent: 8,642,596 →
Application: 11/791,926 →
Publication: US 2009/0203675
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 7,977,365 →
Application: 12/111,778 →
Publication: US 2008/0300265
Anti-Arenaviral Compounds
Patent: 8,106,058 →
Application: 12/162,395 →
Publication: US 2009/0180980
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,148,428 →
Application: 12/281,081 →
Publication: US 2009/0036513
Antiviral Drugs for Treatment or Prevention of Dengue Infection
Patent: 8,518,960 →
Application: 12/601,187 →
Publication: US 2010/0189685
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,461,177 →
Application: 12/673,983 →
Publication: US 2011/0064693
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,623,347 →
Application: 12/735,392 →
Publication: US 2011/0027227
Small Molecule Inhibitors for the Treatment or Prevention of Dengue Virus Infection
Patent: 9,029,376 →
Application: 12/736,965 →
Publication: US 2011/0158940
Anti-Viral Drugs for Treatment of Arenavirus Infection
Patent: 8,629,170 →
Application: 12/912,325 →
Publication: US 2011/0172281
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 8,410,149 →
Application: 12/914,400 →
Publication: US 2012/0022027
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Patent: 8,658,697 →
Application: 12/925,702 →
Publication: US 2011/0118505
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Patent: 8,664,274 →
Application: 13/176,866 →
Publication: US 2013/0261087
Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
Patent: 9,301,949 →
Application: 13/203,351 →
Publication: US 2012/0022046
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,871,746 →
Application: 13/293,849 →
Publication: US 2012/0071447
Anti-Arenaviral Compounds
Patent: 8,518,951 →
Application: 13/338,726 →
Publication: US 2012/0107276
Anti-Arenaviral Compounds
Patent: 8,791,110 →
Application: 13/339,478 →
Publication: US 2012/0308519
Treatment and Prevention of Dengue Virus Infections
Patent: 8,993,604 →
Application: 13/379,776 →
Publication: US 2012/0258079
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 9,199,920 →
Application: 13/402,125 →
Publication: US 2012/0149751
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,492,434 →
Application: 13/402,167 →
Publication: US 2013/0165493
Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens
Patent: 9,233,087 →
Application: 13/578,413 →
Publication: US 2013/0195796
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 28, 2011
From: BYRD, CHELSEA M.; JORDAN, ROBERT; DAI, DONGCHENG; HRUBY, DENNIS E.
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 025869/0552 →
Confirmatory License Jul 17, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028571/0641 →
Confirmatory License Oct 18, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029151/0189 →
Security Agreement Dec 31, 2012
From: SIGA TECHNOLOGIES, INC.
To: GE CAPITAL EQUITY INVESTMENTS, INC. C/O GE HEALTHCARE FINANCIAL SERVICES, INC.
Reel/Frame 029557/0771 →
Release of Security Interest Aug 14, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: SIGA TECHNOLOGIES INC.
Reel/Frame 033544/0324 →
Assignment of Assignor's Interest Aug 22, 2014
From: SIGA TECHNOLOGIES INC.
To: KINETA FOUR LLC
Reel/Frame 033588/0427 →
Security Interest Nov 16, 2016
From: SIGA TECHNOLOGIES, INC.
To: CORTLAND CAPITAL MARKET SERVICES, LLC
Reel/Frame 040349/0219 →
Release of Security Interest in Intellectual Property at Reel/Frame No. 40349/0219 Mar 13, 2020
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 052163/0014 →
Confirmatory License May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0611 →
Confirmatory License May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0609 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0656 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0736 →